EMMESSACommodity Chemicals
Emmessar Biotech & Nutrition Ltd — Profit & Loss Statement
₹23.56
+0.17%
Emmessar Biotech & Nutrition Ltd Profit & Loss Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 28800.00 | 0.07 Cr | — |
| Tax Rate For Calcs | 0.30 | 0.20 | 0.30 | 0.30 | — |
| Normalized EBITDA | 1.06 Cr | -1.08 Cr | -0.68 Cr | -1.07 Cr | — |
| Total Unusual Items | 0.00 | 0.00 | 96000.00 | 0.24 Cr | — |
| Total Unusual Items Excluding Goodwill | 0.00 | 0.00 | 96000.00 | 0.24 Cr | — |
| Net Income From Continuing Operation Net Minority Interest | 0.32 Cr | 0.65 Cr | 0.50 Cr | 0.48 Cr | — |
| Reconciled Depreciation | 0.10 Cr | 0.10 Cr | 0.09 Cr | 0.09 Cr | — |
| Reconciled Cost Of Revenue | 0.18 Cr | 0.20 Cr | 0.40 Cr | 0.13 Cr | — |
| EBITDA | 1.06 Cr | -1.08 Cr | -0.67 Cr | -0.83 Cr | — |
| EBIT | 0.96 Cr | -1.18 Cr | -0.76 Cr | -0.92 Cr | — |
| Net Interest Income | -6000.00 | 0.49 Cr | 0.24 Cr | 0.21 Cr | — |
| Interest Expense | 6000.00 | — | — | — | — |
| Normalized Income | 0.32 Cr | 0.65 Cr | 0.50 Cr | 0.30 Cr | — |
| Net Income From Continuing And Discontinued Operation | 0.32 Cr | 0.65 Cr | 0.50 Cr | 0.48 Cr | — |
| Total Expenses | 1.66 Cr | 1.73 Cr | 1.78 Cr | 1.28 Cr | — |
| Diluted Average Shares | 0.52 Cr | 0.44 Cr | 0.50 Cr | 0.50 Cr | — |
| Basic Average Shares | 0.52 Cr | 0.44 Cr | 0.50 Cr | 0.50 Cr | — |
| Diluted EPS | 0.61 | 1.48 | 0.99 | 0.94 | — |
| Basic EPS | 0.61 | 1.48 | 0.99 | 0.94 | — |
| Diluted NI Availto Com Stockholders | 0.32 Cr | 0.65 Cr | 0.50 Cr | 0.48 Cr | — |
| Net Income Common Stockholders | 0.32 Cr | 0.65 Cr | 0.50 Cr | 0.48 Cr | — |
| Otherunder Preferred Stock Dividend | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income | 0.32 Cr | 0.65 Cr | 0.50 Cr | 0.48 Cr | — |
| Net Income Including Noncontrolling Interests | 0.32 Cr | 0.65 Cr | 0.50 Cr | 0.48 Cr | — |
| Net Income Continuous Operations | 0.32 Cr | 0.65 Cr | 0.50 Cr | 0.48 Cr | — |
| Tax Provision | 0.64 Cr | 0.16 Cr | 0.46 Cr | 0.46 Cr | — |
| Pretax Income | 0.96 Cr | 0.81 Cr | 0.97 Cr | 0.93 Cr | — |
| Other Non Operating Income Expenses | 2.01 Cr | 1.99 Cr | 1.49 Cr | 1.41 Cr | — |
| Special Income Charges | 0.00 | 0.00 | 92000.00 | 0.24 Cr | — |
| Net Non Operating Interest Income Expense | -6000.00 | 0.49 Cr | 0.24 Cr | 0.21 Cr | — |
| Interest Expense Non Operating | 6000.00 | — | — | — | — |
| Operating Income | -1.05 Cr | -1.18 Cr | -0.76 Cr | -0.92 Cr | — |
| Operating Expense | 1.48 Cr | 1.54 Cr | 1.38 Cr | 1.16 Cr | — |
| Other Operating Expenses | 0.45 Cr | 0.48 Cr | 0.30 Cr | 0.17 Cr | — |
| Depreciation And Amortization In Income Statement | 0.10 Cr | 0.10 Cr | 0.09 Cr | 0.09 Cr | — |
| Depreciation Income Statement | 0.10 Cr | 0.10 Cr | 0.09 Cr | 0.09 Cr | — |
| Gross Profit | 0.43 Cr | 0.36 Cr | 0.62 Cr | 0.24 Cr | — |
| Cost Of Revenue | 0.18 Cr | 0.20 Cr | 0.40 Cr | 0.13 Cr | — |
| Total Revenue | 0.61 Cr | 0.56 Cr | 1.02 Cr | 0.36 Cr | — |
| Operating Revenue | 0.61 Cr | 0.56 Cr | 1.02 Cr | 0.36 Cr | — |
| Interest Income | — | 0.49 Cr | 0.24 Cr | 0.21 Cr | 0.11 Cr |
| Rent Expense Supplemental | — | 85000.00 | 85000.00 | 85000.00 | 0.01 Cr |
| Total Other Finance Cost | — | 13000.00 | 13000.00 | 10000.00 | 15379.00 |
| Interest Income Non Operating | — | 0.49 Cr | 0.24 Cr | 0.21 Cr | 0.11 Cr |
| Selling General And Administration | — | 0.18 Cr | 0.14 Cr | 0.12 Cr | 0.08 Cr |
| Selling And Marketing Expense | — | 0.04 Cr | 0.03 Cr | 0.02 Cr | 0.02 Cr |
| General And Administrative Expense | — | 0.14 Cr | 0.12 Cr | 0.10 Cr | 0.06 Cr |
| Rent And Landing Fees | — | 85000.00 | 85000.00 | 85000.00 | 0.01 Cr |
| Other Special Charges | — | — | -92000.00 | -0.24 Cr | — |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Emmessar Biotech & Nutrition Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.